Literature DB >> 20871258

Combining cytotoxic and targeted therapies for lung cancer.

Matjaz Zwitter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20871258     DOI： 10.1097/JTO.0b013e3181e7d04e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial.

Authors:  Matjaz Zwitter; Mirjana Rajer; Viljem Kovac; Izidor Kern; Martina Vrankar; Uros Smrdel
Journal:  J Biomed Biotechnol       Date:  2011-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.